Drug Database
Back to search

France· FR:64805678

NEXVIADYME 100 mg, poudre pour solution à diluer pour perfusion

A avalglucosidase alfa product containing avalglucosidase alfa, registered in France by SANOFI (PAYS-BAS). The same ATC class is registered in 14 of our 19 countries.

ATC A16AB22

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedNEXVIADYME 100 mg, poudre pour soluti…ATCA16AB22REGISTER NO.FR:64805678PACKS LISTED1CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about avalglucosidase alfaAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Avalglucosidase alfa is registered in 14 of 19 countries.

Countries holding a registration under ATC A16AB22 (avalglucosidase alfa), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 9 of them publish a price we can compare per daily dose
Search avalglucosidase alfa products by name

Avalglucosidase alfa · ATC A16AB22

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of avalglucosidase alfa costs, country by country.

Normalised to the WHO defined daily dose (0.1 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Avalglucosidase alfa · price per daily dose (0.1 g)

USD · FX 28 Sept 2026

  • CH Switzerland$1265.54
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
AVALGLUCOSIDASE ALFA
Manufacturer
SANOFI (PAYS-BAS)
Country
France (FR)
ATC code
A16AB22
ATC class
Avalglucosidase alfa
Defined daily dose
0.1 g, P
Reimbursed
No
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

  • cip13
    3400930240601
    1 flacon(s) en verre de 100 mg

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Avalglucosidase alfa in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All avalglucosidase alfa products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Nexviadyme
  • Liechtenstein · Nexviadyme
  • Norway · Nexviadyme

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/8f70e4c2-f240-4a47-8836-512fb6bd171f
GET /v1/drugs/8f70e4c2-f240-4a47-8836-512fb6bd171f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "64805678",
  "date_amm": "2022-06-24",
  "type_amm": "Procédure centralisée",
  "numero_ue": "EU/1/21/1579",
  "substance": "AVALGLUCOSIDASE ALFA",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "poudre pour solution à diluer pour perfusion",
  "voies_administration": "intraveineuse",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Oui"
}
API referenceMCP serverPlans

See everything about avalglucosidase alfa.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console